×
About 263 results

ALLMedicine™ Diuretics Center

Research & Reviews  61 results

Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
https://doi.org/10.1002/ehf2.14030
ESC Heart Failure; Imaeda S, Shiraishi Y et. al.

Jun 23rd, 2022 - Furosemide, a short-acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long-acting loop diuretics (LD), such as torsemide or azosemide, might have more ...

The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome T...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722345
BMC Nephrology; Chávez-Iñiguez JS, Ibarra-Estrada M et. al.

Jan 5th, 2022 - The main treatment strategy in type 1 cardiorenal syndrome (CRS1) is vascular decongestion. It is probable that sequential blockage of the renal tubule with combined diuretics (CD) will obtain similar benefits compared with stepped-dose furosemide...

Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716424
British Journal of Pharmacology; Denys IB, Gao J et. al.

Oct 28th, 2021 - Partial agonists of the nociceptin opioid peptide (NOP) receptor have potential therapeutic use as antihypertensive and water diuretics (aquaretics). To date, peptide NOP receptor ligands have failed to progress in clinical trials due to poor phar...

Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599022
European Heart Journal; Cox ZL, Rao VS et. al.

Sep 17th, 2021 - In healthy volunteers, the kidney deploys compensatory post-diuretic sodium reabsorption (CPDSR) following loop diuretic-induced natriuresis, minimizing sodium excretion and producing a neutral sodium balance. CPDSR is extrapolated to non-euvolemi...

Contradiction between genetic analysis and diuretic loading test in type I Bartter synd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404274
BMC Nephrology; Kuroda J, Harada R et. al.

Sep 1st, 2021 - In typical cases of Bartter syndrome (BS), assessing response to diuretics (furosemide and thiazide), hereinafter referred to as diuretic loading test, may be used to diagnose the type by detecting which part of the kidney tubule is not functionin...

see more →

Drugs  35 results

Ramipril - ramipril capsule-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20676a93-af57-40ff-827d-f80892af7517

Feb 28th, 2022 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Altace - ramipril capsule-Pfizer Laboratories Div Pfizer Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046

Feb 15th, 2022 - ALTACE is an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial...

Ramipril - ramipril capsule-Northwind Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab324cb3-2aaa-b57f-e053-2995a90a2055

Jan 14th, 2022 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Ramipril - ramipril capsule-Northwind Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab3124b7-deed-8e04-e053-2a95a90a3b85

Dec 31st, 2021 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Ramipril - ramipril capsule-Exelan Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e1dfacf-b831-4743-a874-9a5e5ef8a120

Oct 1st, 2021 - Ramipril is an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardi...

see more →

News  9 results

Loop Diuretics: Getting the Dose Right
https://www.medscape.com/viewarticle/915184

Jul 10th, 2019 - Loop diuretics are widely used in the management of edema and heart failure. They are also widely misunderstood. The reason is this: Loop diuretics are often prescribed in a dose-dependent strategy. Looking for gentle diuresis? Prescribe a low dos...

Quarter of Seniors Off HTN Meds; Early Birth or Menopause Risky; Drink Daily for Afib?
https://www.medpagetoday.com/cardiology/prevention/60267

Sep 16th, 2016 - The CDC reported that 26% of Medicare Part D beneficiaries on antihypertension medication didn't adhere to it, corresponding to 4.9 million Americans. The report in Morbidity and Mortality Weekly Report showed higher nonadherence rates with diuret...

Diabetes Risk Grows as Heart Failure Worsens
https://www.medpagetoday.com/cardiology/chf/45914

May 21st, 2014 - Worsening heart failure severity -- indicated by increasing doses of loop diuretics -- was associated in a dose-dependent manner with rising risks of developing diabetes, a Danish study showed. The risk of developing diabetes was about three times...

Hypertension Highlights: Does It All Begin and End With ALLHAT?
https://www.medscape.com/viewarticle/718411

Mar 18th, 2010 - This Hypertension Highlights newsletter kicked off 7 years ago in December 2002 with the first results of what is still the largest hypertension trial ever conducted. I'm referring, of course, to the Antihypertensive and Lipid-Lowering Treatment t...

Dyspnea in a Woman With Alcoholic Cirrhosis
https://www.medscape.com/viewarticle/433739_3

Jun 24th, 2002 - Management Questions What treatment modalities are effective in patients with hepatic hydrothorax? The first step in treatment should be to create a negative sodium balance by restricting sodium intake (< 90 mEq/day) and administering diuretics (s...

see more →